Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nokian Tyres OYJ Unsponsored Finland ADR NKRKY

Nokian Tyres plc is a Finland-based company active in the tire manufacturing industry. The Company diversifies its activities into three main business segments: Passenger Car Tires, Heavy Tires and Vianor. The Passenger Car Tires business segment comprises the development and production of summer and winter tires for cars and vans. The Heavy Tires business segment comprises tires for forestry... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (PINL:NKRKY)

No current opinion is available.

Bullboard Posts (PINL:NKRKY)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
CoressPrings - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
CoressPrings - July 14, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
CoressPrings - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
CoressPrings - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

CoressPrings - May 10, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
CoressPrings - April 30, 2022